Two large employers, Ascension in St
Anti-inflammatory effects of glucagon-like peptide-1 (GLP-1) in coronary artery disease: a comprehensive review
Industry Funding: From the study, the trial was funded by Eli Lilly
What is the best time to inject GHK-Cu
The SELECT cardiovascular outcomes trial (N=17,604), published in NEJM 2023 (DOI: 10.1056/NEJMoa2307563), demonstrated a 20% reduction in major adverse cardiovascular events (MACE) -- the composite of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke -- in overweight or obese adults without diabetes
Explaining what the synthetic hormone-like peptide does, Cancer Research UK states: "It stimulates the pigment cells in your skin to produce more melanin, and this makes the skin look darker